Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:1067-1068

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingwall, J. S.
Right arrow Articles by Kelly, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingwall, J. S.
Right arrow Articles by Kelly, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
(Circulation Research. 1998;83:1067-1068.)
© 1998 American Heart Association, Inc.


Editorial

Nitric Oxide, Myocardial Oxygen Consumption, and ATP Synthesis

Joanne S. Ingwall, , Ralph A. Kelly

From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.

Correspondence to Joanne S. Ingwall, PhD, NMR Laboratory, Brigham and Women's Hospital, 221 Longwood Ave, Room 247, Boston, MA 02115. E-mail ingwall@bustoff.bwh.harvard.edu


Key Words: nitric oxide • oxygen consumption • ATP synthesis • heart • metabolic substrate

NO is a free radical gas, NO{bullet}, in equilibrium with the closely related redox forms NO- and NO+. With a molecular weight of only 30 Da/mol (for reference, molecular oxygen is 32 Da/mol), NO is readily diffusible. The half-life of NO is 0.1 to 5 seconds. NO synthesis is catalyzed by a family of proteins, NO synthases (NOSs). The NOS originally described as the source of NO in conduit vessel endothelial cells (eNOS or NOS3) has been found in the endothelium of the endocardium and the coronary vasculature, in atrial and ventricular myocytes, and in conduction cells of the heart.1 2 3

Because NO is readily diffusible, it can affect many molecular targets. Molecular oxygen is itself a target, forming NO2, which in turn forms NO2-, and NO3-. NO reacts with the free radical superoxide O2- to form the highly reactive species peroxynitrite ONOO-. NO also reacts with iron to form Fe2+NO complexes and with amino, thiol, diazo, and tyrosyl groups in proteins. On the basis of this chemistry, the macromolecular targets of NO and its derivatives in cells can be understood. For example, activation of the signal transduction protein guanylyl cyclase occurs via NO binding to its heme. Inhibition of creatine kinase and some of the glycolytic proteins, including GAPDH, by NO occurs by binding to labile reactive -SH groups. Thus, NO functions to alter macromolecular function in 2 distinct ways: by direct chemical modification and by activation of the guanylyl cyclase signaling pathway.

NO and ATP Synthesis

NO . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
E. A. Bacha, F. J. Zimmerman, V. Mor-Avi, L. Weinert, J. P. Starr, L. Sugeng, and R. M. Lang
Ventricular Resynchronization by Multisite Pacing Improves Myocardial Performance in the Postoperative Single-Ventricle Patient
Ann. Thorac. Surg., November 1, 2004; 78(5): 1678 - 1683.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. S. Nelson, R. D. Berger, B. J. Fetics, M. Talbot, J. C. Spinelli, J. M. Hare, and D. A. Kass
Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block
Circulation, December 19, 2000; 102(25): 3053 - 3059.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-W. Sun, J. R. Falck, H. Okamoto, D. R. Harder, and R. J. Roman
Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H339 - H350.
[Abstract] [Full Text] [PDF]